FR2510406B1 - Composition pharmaceutique contenant en association de la 6,7-dichloro-1,5-dihydroimidazo (2,1-b) quinazoline-2(3h)-one et un agent anti-inflammatoire - Google Patents
Composition pharmaceutique contenant en association de la 6,7-dichloro-1,5-dihydroimidazo (2,1-b) quinazoline-2(3h)-one et un agent anti-inflammatoireInfo
- Publication number
- FR2510406B1 FR2510406B1 FR8213262A FR8213262A FR2510406B1 FR 2510406 B1 FR2510406 B1 FR 2510406B1 FR 8213262 A FR8213262 A FR 8213262A FR 8213262 A FR8213262 A FR 8213262A FR 2510406 B1 FR2510406 B1 FR 2510406B1
- Authority
- FR
- France
- Prior art keywords
- dihydroimidazo
- quinazoline
- dichloro
- combination
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/288,639 US4357330A (en) | 1981-07-30 | 1981-07-30 | Pharmaceutical compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2510406A1 FR2510406A1 (fr) | 1983-02-04 |
| FR2510406B1 true FR2510406B1 (fr) | 1986-05-09 |
Family
ID=23107996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR8213262A Expired FR2510406B1 (fr) | 1981-07-30 | 1982-07-29 | Composition pharmaceutique contenant en association de la 6,7-dichloro-1,5-dihydroimidazo (2,1-b) quinazoline-2(3h)-one et un agent anti-inflammatoire |
Country Status (12)
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3524051A1 (de) * | 1985-07-05 | 1987-01-15 | Hoechst Ag | Kombinationspraeparate aus hemmstoffen der thrombozytenaggregation und deren verwendung |
| US4837239A (en) * | 1985-08-23 | 1989-06-06 | Syntex (U.S.A.) Inc. | Cardiotonic phosphodiesterase inhibitors complexed with water soluble vitamins |
| EP0270316A3 (en) * | 1986-12-04 | 1989-12-06 | Pfizer Inc. | Topical compositions comprising 1-substituted imidazoles and nsaids for treatment of acne |
| AT393962B (de) * | 1987-10-22 | 1992-01-10 | Thomae Gmbh Dr K | Synergistische arzneimittelkombination mit einem gehalt an einem phosphodiesterase-hemmer und derenverwendung |
| CA2171073A1 (en) * | 1995-12-04 | 1997-06-05 | Philip C. Lang | Process for the preparation of ethyl-n-(2,3 dichloro-6- nitrobenzyl) glycine |
| AU7604400A (en) * | 1999-09-21 | 2001-04-24 | Emory University | Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents |
| US6194420B1 (en) | 1999-11-30 | 2001-02-27 | Roberts Laboratories Inc. | 2-amino-5,6-dichloro-3,4-dihydroquinazoline, its method of making and using and pharmaceutical compositions thereof |
| US6388073B1 (en) | 2000-07-26 | 2002-05-14 | Shire Us Inc. | Method for the manufacture of anagrelide |
| WO2004064841A1 (en) * | 2003-01-23 | 2004-08-05 | Shire Holdings Ag | Formulation and methods for the treatment of thrombocythemia |
| US7700608B2 (en) | 2004-08-04 | 2010-04-20 | Shire Holdings Ag | Quinazoline derivatives and their use in the treatment of thrombocythemia |
| US20060030574A1 (en) * | 2004-08-04 | 2006-02-09 | Shire Holdings Ag | Quinazoline derivatives useful for the treatment of peripheral arterial disease and as phosphodiesterase inhibitors |
| US7910597B2 (en) * | 2006-11-28 | 2011-03-22 | Shire Llc | Substituted quinazolines |
| US8304420B2 (en) * | 2006-11-28 | 2012-11-06 | Shire Llc | Substituted quinazolines for reducing platelet count |
| CN101463035A (zh) * | 2007-12-19 | 2009-06-24 | 华生制药私人有限公司 | 生产盐酸阿那格雷一水合物的改进方法 |
| GB2462022B (en) | 2008-06-16 | 2011-05-25 | Biovascular Inc | Controlled release compositions of agents that reduce circulating levels of platelets and methods thereof |
| GB201017783D0 (en) | 2010-10-21 | 2010-12-01 | Shire Llc | Process for the preparation of anagrelide and analogues thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2307538A1 (fr) * | 1975-04-18 | 1976-11-12 | Centre Etd Ind Pharma | Nouveau medicament anti-agregant plaquettaire |
| US4124715A (en) | 1977-05-16 | 1978-11-07 | Jose Pozuelo | Method of pharmacologically treating drug addiction with fusaric acid |
-
1981
- 1981-07-30 US US06/288,639 patent/US4357330A/en not_active Expired - Lifetime
-
1982
- 1982-06-04 CA CA000404552A patent/CA1181010A/en not_active Expired
- 1982-07-27 ZA ZA825397A patent/ZA825397B/xx unknown
- 1982-07-28 AU AU86527/82A patent/AU559161B2/en not_active Expired
- 1982-07-29 LU LU84306A patent/LU84306A1/fr unknown
- 1982-07-29 FR FR8213262A patent/FR2510406B1/fr not_active Expired
- 1982-07-29 DE DE19823228402 patent/DE3228402A1/de active Granted
- 1982-07-29 IE IE1828/82A patent/IE54277B1/en not_active IP Right Cessation
- 1982-07-29 BE BE0/208704A patent/BE893974A/fr not_active IP Right Cessation
- 1982-07-29 GB GB08221932A patent/GB2103090B/en not_active Expired
- 1982-07-30 JP JP57132286A patent/JPS5826817A/ja active Granted
-
1988
- 1988-12-30 MY MY110/88A patent/MY8800110A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA825397B (en) | 1983-06-29 |
| AU8652782A (en) | 1983-02-03 |
| JPH0237328B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1990-08-23 |
| JPS5826817A (ja) | 1983-02-17 |
| IE821828L (en) | 1983-01-30 |
| LU84306A1 (fr) | 1983-04-13 |
| MY8800110A (en) | 1988-12-31 |
| GB2103090A (en) | 1983-02-16 |
| FR2510406A1 (fr) | 1983-02-04 |
| DE3228402A1 (de) | 1983-02-24 |
| BE893974A (fr) | 1983-01-31 |
| US4357330A (en) | 1982-11-02 |
| IE54277B1 (en) | 1989-08-16 |
| CA1181010A (en) | 1985-01-15 |
| DE3228402C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1992-01-23 |
| AU559161B2 (en) | 1987-02-26 |
| GB2103090B (en) | 1985-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2510406B1 (fr) | Composition pharmaceutique contenant en association de la 6,7-dichloro-1,5-dihydroimidazo (2,1-b) quinazoline-2(3h)-one et un agent anti-inflammatoire | |
| IL55183A (en) | 3-substituted-1,5-dihydroimidazo(2,1-b)quinazolin-2(3h)-one derivatives,their preparation and pharmaceutical compositions containing them | |
| FR2559061B1 (fr) | Compositions analgesiques et anti-inflammatoires contenant de la diphenhydramine | |
| FR2511775B1 (fr) | Miroir composite et fabrication de miroir composite | |
| DE3266196D1 (en) | Combined flood and spot light | |
| OA07261A (fr) | Association insecticides et arcaricides à base de pyréthroïde. | |
| FR2586562B1 (fr) | Composition pharmaceutique contenant de l'a-methylhistamine | |
| DE3260051D1 (en) | Benzothiazine dioxide anti-inflammatory agents, processes for their preparation, and pharmaceutical compositions containing them | |
| BE892731A (fr) | Electrodeposition de l'etain et d'alliages d'etain | |
| EP0073819A4 (en) | NASAL ADMINISTRATION OF BETA BLOCKERS AND DOSING FORMS THEREFOR. | |
| FR2503438B1 (fr) | Procede de reduction de volume et d'enrobage de dechets contenant de l'eau | |
| DK268982A (da) | Funktionelle syrehalogenid-og acyllactam-materialer | |
| IL60325A (en) | 7-bromo-1,5-dihydro-3,6-dimethylimidazo(2,1-b)quinazolin-2(3h)-one isomers and tautomers and pharmaceutical preparations containing them | |
| DE3375025D1 (en) | Preparation of optically active cis-1,3-dibenzyl-hexahydro-1h-furo(3,4-d)imidazole-2,4-dione and its intermediates | |
| ES510745A0 (es) | "un metodo de mezclar un gas y un liquido vaporizable". | |
| ES514220A0 (es) | "procedimiento para la fabricacion de (tienil-2)-2 etilaminas y (tienil-3)-2 etilaminas". | |
| GB2097799B (en) | Chlorosulfonation of polyethylene | |
| JPS57165833A (en) | Stable developer containing indasol based fog preventing agent and lignosurphonate | |
| EP0084053A4 (en) | Medicines and the use of Sn or Cr protoporphyrin for its manufacture. | |
| BE892223A (fr) | Disposition d'elements de construction | |
| FR2506647B1 (fr) | Procede de fabrication d'un ensemble forme d'un tube de metal et d'un corps entourant celui-ci | |
| IL66146A (en) | Substituted benzylidenepyrrolo-(2,1-b)quinazolinones and pyrido-(2,1-b)quinazolinones,their preparation and pharmaceutical compositions containing them | |
| ZA804032B (en) | Pharmaceutical compositions containing benzothiazole-2(3h)-ones and use thereof | |
| JPS57165379A (en) | Manufacture of 2,3-dihydro-4h-1,4-benzothiazines | |
| FR2509611B1 (fr) | Nouvel agent anti-acide et composition pharmaceutique le contenant |